| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 213 | 187 | 251 | 207 | 193 | 202 | 212 | 204 | 216 | 234 | 235 | 229 | 256 | 243 | 255 | 328 | 288 | 318 | 321 | 315 | 316 | 297 | 295 | 987 | 44 | 25 | 145 | 359 | 167 | 171 | 178 |
| Expenses | 155 | 136 | 163 | 157 | 148 | 163 | 165 | 156 | 167 | 179 | 178 | 185 | 199 | 180 | 194 | 270 | 227 | 252 | 259 | 267 | 250 | 224 | 236 | 437 | 43 | 24 | 136 | 147 | 149 | 151 | 153 |
| EBITDA | 58 | 51 | 88 | 50 | 46 | 40 | 47 | 48 | 49 | 55 | 57 | 44 | 57 | 63 | 61 | 58 | 60 | 66 | 62 | 47 | 66 | 73 | 59 | 549 | 1 | 1 | 9 | 211 | 18 | 19 | 26 |
| Operating Profit % | 16 % | 19 % | 18 % | 19 % | 21 % | 15 % | 19 % | 19 % | 21 % | 22 % | 21 % | 18 % | 21 % | 24 % | 21 % | 12 % | 19 % | 19 % | 17 % | 12 % | 19 % | 23 % | 18 % | 17 % | -29 % | -99 % | -6 % | -7 % | 2 % | 1 % | -1 % |
| Depreciation | 25 | 26 | 25 | 28 | 23 | 23 | 23 | 22 | 20 | 20 | 20 | 28 | 14 | 14 | 21 | 82 | 16 | 16 | 15 | 9 | 14 | 13 | 14 | 20 | 0 | 0 | 6 | 7 | 7 | 7 | 9 |
| Interest | 5 | 23 | 22 | 27 | 28 | 29 | 29 | 21 | 25 | 25 | 26 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 22 | 22 | 20 | 21 | 21 | 3 | 0 | 0 | 10 | -27 | 1 | 2 | 1 |
| Profit Before Tax | 28 | 3 | 40 | -5 | -6 | -12 | -5 | 4 | 5 | 10 | 12 | -8 | 19 | 25 | 16 | -47 | 20 | 26 | 24 | 16 | 32 | 39 | 24 | 527 | 1 | 1 | -7 | 231 | 10 | 10 | 16 |
| Tax | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 21 | 0 | 1 | -0 | 14 | 0 | 1 | -3 | 41 | 14 | 7 | 5 | 33 | 0 | 0 | -1 | 8 | 2 | 2 | 7 |
| Net Profit | 28 | 3 | 40 | -25 | -6 | -12 | -5 | 3 | 5 | 10 | 12 | -29 | 19 | 25 | 16 | -62 | 20 | 25 | 28 | -25 | 17 | 32 | 19 | 494 | 1 | 0 | -6 | 222 | 9 | 8 | 10 |
| EPS in ₹ | 6.21 | 0.72 | 8.67 | -5.21 | -2.91 | -2.57 | -0.98 | 0.60 | 0.77 | 1.68 | 1.95 | -4.94 | 3.18 | 4.14 | 2.71 | -10.40 | 3.36 | 4.29 | 4.65 | -4.25 | 2.92 | 5.36 | 3.29 | 83.55 | 0.16 | 0.07 | -0.82 | 32.96 | 1.28 | 1.00 | 1.17 |
Ind Swift Laboratories
Ind Swift Laboratories
113.37
+4.72
(4.34%)
Market Cap
925.23 Cr
PE Ratio
3.56
Volume
2,35,423.00
Day High - Low
114.00 - 108.00
52W High-Low
124.00 - 68.72
There are 1 new updates from the company1 day ago
Show All
Key Fundamentals
Market Cap
925.23 Cr
EPS
37.25
PE Ratio
3.56
PB Ratio
0.68
Book Value
160.21
EBITDA
62.00
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
21.36
Debt to Equity
0.11
Actual
Company News
View All News
Ind-Swift Laboratories submits Q3FY26 monitoring agency report for Rs. 314.60 crore preferential issue with no fund utilization during quarter and temporary fund transfer noted.
Ind-Swift Laboratories reported strong Q3FY26 results with net profit of ₹1074.18 lakhs vs loss of ₹86.19 lakhs in Q3FY25. Revenue grew 23% to ₹14948.10 lakhs. Board approved leadership restructuring effective Feb 1, 2026.
Ind-Swift Labs Submits Investor Presentation
Jan 14, 2026
Jan 14, 2026Ind-Swift Laboratories Limited submitted its latest investor presentation to stock exchanges on January 14, 2026, highlighting the company's transformation into a pure-play formulations platform following the ₹1,650 crore API business divestment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,702.10 | #1 4,08,390.81 | 35.68 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 55.15 | |
6,209.00 | 1,64,829.44 | 63.67 | 9,712.00 | 18.67 | 2,191 | 35.10 | 49.38 | |
4,045.60 | 1,36,921.49 | 63.11 | 11,539.40 | 6.99 | 1,911 | 30.46 | 59.47 | |
1,322.80 | 1,06,852.05 | 23.37 | 28,409.50 | 7.12 | 5,291 | -57.18 | 27.86 | |
1,235.40 | 1,03,110.23 | 17.87 | 33,741.20 | 16.73 | 5,725 | -15.28 | 53.92 | |
2,185.90 | 99,851.65 | 22.37 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.91 | |
902.90 | 90,852.87 | #1 17.59 | 23,511.00 | 18.55 | 4,615 | 34.60 | 52.82 | |
2,162.60 | 89,273.22 | 48.11 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 51.00 | |
1,226.10 | 71,212.09 | 19.95 | 32,345.60 | 9.43 | 3,484 | 3.81 | 60.00 | |
5,702.50 | 68,181.94 | 27.36 | 13,458.30 | 3.70 | 2,216 | 10.98 | 51.44 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-64.22 %
Net Income Growth
-53.54 %
Cash Flow Change
86.38 %
ROE
-67.83 %
ROCE
-68.66 %
EBITDA Margin (Avg.)
-55.74 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 2,244 | 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,460 | 1,438 |
| Fixed Assets | 1,117 | 1,099 | 1,042 | 934 | 914 | 843 | 753 | 630 | 588 | 192 | 273 |
| Current Assets | 924 | 926 | 832 | 842 | 836 | 863 | 944 | 1,075 | 1,165 | 960 | 865 |
| Capital Work in Progress | 113 | 79 | 70 | 69 | 20 | 12 | 19 | 10 | 8 | 51 | 0 |
| Investments | 0 | 0 | 18 | 18 | 19 | 18 | 36 | 29 | 30 | 112 | 214 |
| Other Assets | 1,014 | 1,037 | 1,007 | 1,002 | 972 | 998 | 1,011 | 1,131 | 1,199 | 1,106 | 952 |
| Total Liabilities | 2,244 | 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,460 | 1,438 |
| Current Liabilities | 648 | 951 | 1,005 | 936 | 356 | 323 | 315 | 335 | 371 | 433 | 221 |
| Non Current Liabilities | 989 | 746 | 601 | 534 | 980 | 906 | 901 | 866 | 771 | 215 | 45 |
| Total Equity | 606 | 517 | 531 | 553 | 588 | 641 | 603 | 601 | 682 | 812 | 1,173 |
| Reserve & Surplus | 553 | 476 | 486 | 507 | 540 | 581 | 544 | 541 | 622 | 745 | 1,030 |
| Share Capital | 41 | 42 | 46 | 46 | 48 | 60 | 60 | 60 | 60 | 67 | 69 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 3 | -4 | -6 | 23 | -17 | 1 | 14 | -4 | 443 | -67 |
| Investing Activities | -35 | -29 | -31 | -17 | -13 | -9 | -10 | 5 | -13 | -28 | -110 |
| Operating Activities | 98 | 79 | 96 | 73 | -64 | 125 | 135 | 150 | 195 | -187 | -26 |
| Financing Activities | -64 | -48 | -69 | -62 | 100 | -133 | -124 | -141 | -186 | 657 | 69 |
Share Holding
| % Holding | Jan 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sept 2025 | Dec 2025 |
| Promoter | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 40.94 % | 40.94 % | 36.77 % | 39.50 % | 39.50 % | 39.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.17 % | 0.00 % | 0.25 % | 1.26 % | 0.85 % | 0.65 % | 0.46 % | 3.07 % | 4.27 % | 0.00 % | 0.00 % | 14.80 % | 14.33 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 19.49 % | 19.49 % | 19.49 % | 19.49 % | 19.49 % | 0.00 % | 8.03 % | 0.94 % | 0.94 % | 0.94 % | 0.94 % | 0.91 % | 0.91 % | 0.00 % | 0.00 % | 0.68 % | 0.68 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.38 % | 27.72 % | 26.78 % | 29.03 % | 29.21 % | 29.31 % | 29.55 % | 29.06 % | 28.97 % | 29.08 % | 29.20 % | 28.77 % | 29.26 % | 30.46 % | 36.69 % | 36.80 % | 36.63 % | 38.11 % | 37.61 % | 41.36 % | 35.11 % | 34.75 % | 34.96 % | 35.06 % |
| Others | 31.62 % | 30.28 % | 31.22 % | 28.98 % | 28.80 % | 28.68 % | 28.44 % | 9.44 % | 9.54 % | 9.43 % | 9.30 % | 9.56 % | 28.73 % | 19.26 % | 19.11 % | 19.41 % | 19.78 % | 18.49 % | 17.46 % | 12.51 % | 28.12 % | 25.76 % | 10.06 % | 10.43 % |
| No of Share Holders | 14,525 | 15,859 | 21,466 | 25,225 | 24,528 | 25,342 | 24,910 | 24,226 | 24,456 | 23,397 | 22,962 | 25,405 | 24,633 | 22,439 | 25,461 | 29,536 | 28,883 | 28,752 | 28,190 | 28,709 | 28,539 | 28,892 | 43,780 | 42,121 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Oct 2023 |  Extraordinary General Meeting | NA | 06 Oct 2023 | 102.85 | 89.69 |
| 22 Jul 2024 | Extraordinary General Meeting | NA | 22 Jul 2024 | 127.65 | 130.35 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 149.05 | 131.75 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 115.20 | 112.50 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 103.70 | 91.90 |
| 22 Feb 2025 | Extraordinary General Meeting | NA | 22 Feb 2025 | 106.65 | 93.80 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 73.68 | 79.52 |
| 11 Aug 2025 | Quarterly Result Announcement | NA | 11 Aug 2025 | 104.60 | 99.80 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 106.67 | 104.95 |
| 14 Aug 2025 |  Merger - Demerger | 100:15 | 14 Aug 2025 | 105.59 | 105.59 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 97.98 | 99.93 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 100.95 | 102.80 |
| 31 Jan 2026 | Quarterly Result Announcement | NA | 31 Jan 2026 | 106.67 | 113.34 |
Announcements
Announcement under Regulation 30 (LODR)-Monitoring Agency Report7 hrs ago
7 hrs agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoStatement Of NIL Deviation For The Quarter Ended December 31 20253 days ago
3 days agoFinancial Results For The Quarter Ended December 31 2025 On Standalone And Consolidated Basis.3 days ago
3 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Held On January 31 20263 days ago
3 days agoBoard Meeting Intimation for Meeting Of The Board Of Directors Scheduled To Be Held On January 31 2026.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 14, 2026
Jan 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Reliance Upon Exemption Provided For In Regulation 10 Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For Inter-Se Transfer Of SharesDec 18, 2025
Dec 18, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Dec 18, 2025
Dec 18, 2025Receipt Of Good Manufacturing Practice (GMP) Certificate From National Center For Public Health And Pharmacy (NNGYK-Hungary).Dec 15, 2025
Dec 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 08, 2025
Dec 08, 2025Intimation Of Trading Approval Obtained From Stock Exchanges For 8124698 Equity Shares Of ?10/- Each Issued Pursuant To The Approved Scheme Of AmalgamationDec 05, 2025
Dec 05, 2025Intimation Regarding Receipt Of ISO 14001:2015 And ISO 45001:2018 CertificationsNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Meeting To Be Held On 14/11/2025Nov 07, 2025
Nov 07, 2025UPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATIONNov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Intimation Regarding Outcome Of The Meeting Of Investment Committee Of The Board.Sep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Sep 11, 2025Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Reliance Upon Exemption Provided For In Regulation 10 Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For Inter-Se Transfer Of SharesSep 10, 2025
Sep 10, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Sep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 07, 2025
Sep 07, 2025Notice Of The 30Th Annual General Meeting Of The Company For The Financial Year 2024-25.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Intimation Of Book Closure Pursuant To Regulation 42 Of SEBI (LODR) Regulations 2015Sep 01, 2025
Sep 01, 2025INTIMATION OF THE 30TH ANNUAL GENERAL MEETING E-VOTING AND BOOK CLOSURE FOR THE FINANCIAL YEAR 2024-25.Sep 01, 2025
Sep 01, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 30, 2025
Aug 30, 2025Disclosure Under Regulation 7(2)(B) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (SEBI (PIT) Regulations 2015)Aug 28, 2025
Aug 28, 2025Disclosure Pursuant To Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-AllotmentAug 25, 2025
Aug 25, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 25 2025Aug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2025
Aug 14, 2025Standalone And Consolidated Un-Audited Financial Results Of Ind-Swift Laboratories Limited For The Quarter Ended 30Th June 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 13TH AUGUST 2025Aug 13, 2025
Aug 13, 2025Results-Delay in Financial ResultsAug 11, 2025
Aug 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated August 11 2025Aug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementAug 08, 2025
Aug 08, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 04, 2025
Aug 04, 2025Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2025.Aug 02, 2025
Aug 02, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31 2025.Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesAug 01, 2025
Aug 01, 2025Technical Indicators
RSI(14)
Neutral 58.56
ATR(14)
Volatile 6.34
STOCH(9,6)
Neutral 58.34
STOCH RSI(14)
Neutral 51.44
MACD(12,26)
Bullish 0.61
ADX(14)
Strong Trend 37.39
UO(9)
Bearish 44.13
ROC(12)
Uptrend But Slowing Down 7.87
WillR(14)
Neutral -35.38
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
